BCPC (Balchem) 1-Year Sharpe Ratio: 0.18 (As of Jul. 10, 2026)


BCPC Balchem Corp BCPC
94 GF Score
Price $162.00
GF Value $177.61
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Balchem 1-Year Sharpe Ratio?

Balchem BCPC -0.84% 94 1-Year Sharpe Ratio is 0.18 as of Jul. 10, 2026. GuruFocus rates BCPC with a GF Score™ of 94/100 and a GF Value™ of $177.61 (Fairly Valued). The stock has 1 warning sign investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-10), Balchem's 1-Year Sharpe Ratio is 0.18.

Balchem  (NAS:BCPC) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Balchem 1-Year Sharpe Ratio Related Terms

BCPC vs PRM, SXT, CBT: 1-Year Sharpe Ratio Comparison

For the Specialty Chemicals subindustry, Balchem's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Balchem 1-Year Sharpe Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Balchem's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Balchem's 1-Year Sharpe Ratio falls into.


BCPC
94GF Score
Balchem Corp BCPC
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Balchem 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.18 mean?
Balchem (BCPC) has a 1-Year Sharpe Ratio of 0.18 as of Jul. 10, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Balchem and its competitors.
Is Balchem's 1-Year Sharpe Ratio too high?
Balchem's current 1-Year Sharpe Ratio is 0.18. Overall, Balchem has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Balchem's 1-Year Sharpe Ratio compare to PRM and SXT?
Balchem's 1-Year Sharpe Ratio of 0.18 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Chemicals company?
A good 1-Year Sharpe Ratio depends on the Chemicals industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Balchem and its competitors. Balchem's current 1-Year Sharpe Ratio is 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balchem stock overvalued right now?
Based on GuruFocus' analysis, Balchem (BCPC) is currently considered Fairly Valued. The stock's GF Value™ is $177.61, compared to a current price of $162.00 — trading 8.8% below its estimated fair value. The current 1-Year Sharpe Ratio is 0.18. Balchem's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Balchem (BCPC), the current 1-Year Sharpe Ratio is 0.18 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Balchem (BCPC) Overvalued in 2026?

Based on GuruFocus' analysis, Balchem stock appears to be undervalued. The current stock price of $162.00 is trading 8.8% below its estimated GF Value™ of $177.61. GuruFocus considers Balchem to be Fairly Valued.

Key valuation signals for BCPC:

  • 1-Year Sharpe Ratio: 0.18
  • GF Value™: $177.61 vs. price of $162.00 (8.8% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the BCPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Balchem Business Description

Other Exchanges BL9B:Germany
Address 5 Paragon Drive, Montvale, NJ, USA, 07645
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
94GF Score

Get the complete analysis for BCPC

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$162.00
Price
$177.61
GF Value